Logo image of NMRK

NEWMARK GROUP INC-CLASS A (NMRK) Stock Fundamental Analysis

NASDAQ:NMRK - Nasdaq - US65158N1028 - Common Stock - Currency: USD

14.9  +0.46 (+3.19%)

Premarket: 15.21 +0.31 (+2.08%)

Fundamental Rating

4

NMRK gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. While NMRK is still in line with the averages on profitability rating, there are concerns on its financial health. NMRK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year NMRK was profitable.
In the past year NMRK has reported a negative cash flow from operations.
In the past 5 years NMRK has always been profitable.
NMRK had negative operating cash flow in 4 of the past 5 years.
NMRK Yearly Net Income VS EBIT VS OCF VS FCFNMRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.42%, NMRK is in the better half of the industry, outperforming 70.31% of the companies in the same industry.
NMRK's Return On Equity of 5.20% is fine compared to the rest of the industry. NMRK outperforms 76.56% of its industry peers.
NMRK has a Return On Invested Capital of 2.83%. This is in the better half of the industry: NMRK outperforms 68.75% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NMRK is in line with the industry average of 5.48%.
Industry RankSector Rank
ROA 1.42%
ROE 5.2%
ROIC 2.83%
ROA(3y)1.46%
ROA(5y)4.08%
ROE(3y)5.18%
ROE(5y)16.9%
ROIC(3y)4.15%
ROIC(5y)7.06%
NMRK Yearly ROA, ROE, ROICNMRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

1.3 Margins

NMRK has a better Profit Margin (2.40%) than 67.19% of its industry peers.
In the last couple of years the Profit Margin of NMRK has declined.
NMRK has a Operating Margin of 6.16%. This is in the better half of the industry: NMRK outperforms 68.75% of its industry peers.
In the last couple of years the Operating Margin of NMRK has declined.
NMRK has a Gross Margin of 99.00%. This is amongst the best in the industry. NMRK outperforms 100.00% of its industry peers.
NMRK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.16%
PM (TTM) 2.4%
GM 99%
OM growth 3Y-48.37%
OM growth 5Y-14.71%
PM growth 3Y-55.64%
PM growth 5Y-13.83%
GM growth 3Y-0.05%
GM growth 5Y0.03%
NMRK Yearly Profit, Operating, Gross MarginsNMRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

2

2. Health

2.1 Basic Checks

NMRK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
NMRK has less shares outstanding than it did 1 year ago.
NMRK has less shares outstanding than it did 5 years ago.
NMRK has a worse debt/assets ratio than last year.
NMRK Yearly Shares OutstandingNMRK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NMRK Yearly Total Debt VS Total AssetsNMRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.53, we must say that NMRK is in the distress zone and has some risk of bankruptcy.
NMRK has a Altman-Z score (1.53) which is comparable to the rest of the industry.
NMRK has a Debt/Equity ratio of 1.20. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.20, NMRK is doing worse than 70.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF N/A
Altman-Z 1.53
ROIC/WACC0.42
WACC6.72%
NMRK Yearly LT Debt VS Equity VS FCFNMRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

NMRK has a Current Ratio of 1.01. This is a normal value and indicates that NMRK is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.01, NMRK is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
A Quick Ratio of 1.01 indicates that NMRK should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.01, NMRK perfoms like the industry average, outperforming 40.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 1.01
NMRK Yearly Current Assets VS Current LiabilitesNMRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

NMRK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.27%, which is quite impressive.
NMRK shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.17% yearly.
The Revenue has grown by 10.85% in the past year. This is quite good.
The Revenue has been growing slightly by 4.31% on average over the past years.
EPS 1Y (TTM)27.27%
EPS 3Y-9.02%
EPS 5Y-5.17%
EPS Q2Q%40.91%
Revenue 1Y (TTM)10.85%
Revenue growth 3Y-1.96%
Revenue growth 5Y4.31%
Sales Q2Q%19.85%

3.2 Future

Based on estimates for the next years, NMRK will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.37% on average per year.
The Revenue is expected to grow by 7.88% on average over the next years.
EPS Next Y16.28%
EPS Next 2Y18.4%
EPS Next 3Y14.58%
EPS Next 5Y11.37%
Revenue Next Year14.83%
Revenue Next 2Y12.22%
Revenue Next 3Y10.51%
Revenue Next 5Y7.88%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NMRK Yearly Revenue VS EstimatesNMRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
NMRK Yearly EPS VS EstimatesNMRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.64 indicates a reasonable valuation of NMRK.
Compared to the rest of the industry, the Price/Earnings ratio of NMRK indicates a rather cheap valuation: NMRK is cheaper than 90.63% of the companies listed in the same industry.
NMRK is valuated cheaply when we compare the Price/Earnings ratio to 27.61, which is the current average of the S&P500 Index.
NMRK is valuated reasonably with a Price/Forward Earnings ratio of 8.50.
Based on the Price/Forward Earnings ratio, NMRK is valued cheaper than 96.88% of the companies in the same industry.
NMRK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.13.
Industry RankSector Rank
PE 10.64
Fwd PE 8.5
NMRK Price Earnings VS Forward Price EarningsNMRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NMRK is valued cheaper than 90.63% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.53
NMRK Per share dataNMRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NMRK's earnings are expected to grow with 14.58% in the coming years.
PEG (NY)0.65
PEG (5Y)N/A
EPS Next 2Y18.4%
EPS Next 3Y14.58%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.83%, NMRK is not a good candidate for dividend investing.
NMRK's Dividend Yield is rather good when compared to the industry average which is at 3.54. NMRK pays more dividend than 82.81% of the companies in the same industry.
With a Dividend Yield of 0.83, NMRK pays less dividend than the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 0.83%

5.2 History

The dividend of NMRK decreases each year by -21.25%.
NMRK has been paying a dividend for over 5 years, so it has already some track record.
NMRK has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-21.25%
Div Incr Years0
Div Non Decr Years3
NMRK Yearly Dividends per shareNMRK Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

NMRK pays out 30.28% of its income as dividend. This is a sustainable payout ratio.
DP30.28%
EPS Next 2Y18.4%
EPS Next 3Y14.58%
NMRK Yearly Income VS Free CF VS DividendNMRK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
NMRK Dividend Payout.NMRK Dividend Payout, showing the Payout Ratio.NMRK Dividend Payout.PayoutRetained Earnings

NEWMARK GROUP INC-CLASS A

NASDAQ:NMRK (7/30/2025, 8:00:02 PM)

Premarket: 15.21 +0.31 (+2.08%)

14.9

+0.46 (+3.19%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners71.53%
Inst Owner Change-0.17%
Ins Owners3.55%
Ins Owner Change-24.41%
Market Cap2.75B
Analysts81.82
Price Target15.17 (1.81%)
Short Float %2.28%
Short Ratio2.9
Dividend
Industry RankSector Rank
Dividend Yield 0.83%
Yearly Dividend0.12
Dividend Growth(5Y)-21.25%
DP30.28%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-14 2025-05-14 (0.03)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.58%
Min EPS beat(2)8.36%
Max EPS beat(2)12.81%
EPS beat(4)4
Avg EPS beat(4)8.47%
Min EPS beat(4)3.95%
Max EPS beat(4)12.81%
EPS beat(8)5
Avg EPS beat(8)1.39%
EPS beat(12)6
Avg EPS beat(12)1.69%
EPS beat(16)10
Avg EPS beat(16)8.61%
Revenue beat(2)2
Avg Revenue beat(2)8.89%
Min Revenue beat(2)7.64%
Max Revenue beat(2)10.13%
Revenue beat(4)2
Avg Revenue beat(4)3.72%
Min Revenue beat(4)-1.48%
Max Revenue beat(4)10.13%
Revenue beat(8)4
Avg Revenue beat(8)2.21%
Revenue beat(12)5
Avg Revenue beat(12)0.65%
Revenue beat(16)9
Avg Revenue beat(16)2.79%
PT rev (1m)0%
PT rev (3m)-7.51%
EPS NQ rev (1m)-0.27%
EPS NQ rev (3m)-9.43%
EPS NY rev (1m)0%
EPS NY rev (3m)0.07%
Revenue NQ rev (1m)-0.7%
Revenue NQ rev (3m)-2.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.66%
Valuation
Industry RankSector Rank
PE 10.64
Fwd PE 8.5
P/S 0.96
P/FCF N/A
P/OCF N/A
P/B 2.08
P/tB N/A
EV/EBITDA 9.53
EPS(TTM)1.4
EY9.4%
EPS(NY)1.75
Fwd EY11.76%
FCF(TTM)-0.82
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS15.48
BVpS7.16
TBVpS-0.14
PEG (NY)0.65
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.42%
ROE 5.2%
ROCE 5.71%
ROIC 2.83%
ROICexc 2.95%
ROICexgc 4.6%
OM 6.16%
PM (TTM) 2.4%
GM 99%
FCFM N/A
ROA(3y)1.46%
ROA(5y)4.08%
ROE(3y)5.18%
ROE(5y)16.9%
ROIC(3y)4.15%
ROIC(5y)7.06%
ROICexc(3y)4.5%
ROICexc(5y)8.1%
ROICexgc(3y)9.76%
ROICexgc(5y)14.35%
ROCE(3y)7.43%
ROCE(5y)14.71%
ROICexcg growth 3Y-48.74%
ROICexcg growth 5Y-20.91%
ROICexc growth 3Y-49.32%
ROICexc growth 5Y-18.85%
OM growth 3Y-48.37%
OM growth 5Y-14.71%
PM growth 3Y-55.64%
PM growth 5Y-13.83%
GM growth 3Y-0.05%
GM growth 5Y0.03%
F-Score6
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF N/A
Debt/EBITDA 4.51
Cap/Depr 17.78%
Cap/Sales 1.1%
Interest Coverage 3.28
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 1.01
Altman-Z 1.53
F-Score6
WACC6.72%
ROIC/WACC0.42
Cap/Depr(3y)29.92%
Cap/Depr(5y)23.99%
Cap/Sales(3y)1.92%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.27%
EPS 3Y-9.02%
EPS 5Y-5.17%
EPS Q2Q%40.91%
EPS Next Y16.28%
EPS Next 2Y18.4%
EPS Next 3Y14.58%
EPS Next 5Y11.37%
Revenue 1Y (TTM)10.85%
Revenue growth 3Y-1.96%
Revenue growth 5Y4.31%
Sales Q2Q%19.85%
Revenue Next Year14.83%
Revenue Next 2Y12.22%
Revenue Next 3Y10.51%
Revenue Next 5Y7.88%
EBIT growth 1Y-15.08%
EBIT growth 3Y-49.38%
EBIT growth 5Y-11.04%
EBIT Next Year99.61%
EBIT Next 3Y38.23%
EBIT Next 5Y24.29%
FCF growth 1Y-167.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-140.82%
OCF growth 3YN/A
OCF growth 5YN/A